The global biomaterials market was valued at USD 178.0 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 15.6% from 2024 to 2030. This growth is driven by several factors, including the increasing incidence of musculoskeletal and chronic skeletal conditions, which are spurring greater demand for implants and medical devices made from biomaterials. With the aging population and rising rates of conditions like osteoarthritis, degenerative diseases, and bone fractures, the need for advanced biomaterials is becoming more pronounced. These materials are critical for joint replacements, bone augmentations, and other orthopedic interventions that help individuals regain mobility and improve their quality of life.

Market Drivers

The increasing prevalence of chronic skeletal conditions such as osteoarthritis and degenerative diseases is a major driver of the biomaterials market. These conditions often result in pain, limited mobility, and reduced quality of life, prompting the need for medical interventions like joint replacements. In particular, joint replacement surgeries, such as knee and hip replacements, are among the most common treatments for these conditions. As the number of patients requiring these procedures continues to rise, so does the demand for biomaterial-based implants that offer durable and long-lasting solutions.

Metallic biomaterials, such as titanium and stainless steel, are particularly in demand because of their ability to withstand high mechanical loads while being compatible with the human body. These materials are used in orthopedic implants, including joint replacements and spinal devices, where strength and durability are essential. Innovations in biomaterial technologies continue to enhance the biocompatibility, corrosion resistance, and integration of these materials with human tissues, making them an increasingly attractive option in medical procedures.

Technological advancements are consistently refining biomaterials, making them more tailored and effective for specific medical needs. Innovations are focused on improving the performance of biomaterials in terms of their interaction with biological systems, which helps to reduce complications and improve patient outcomes.

Gather more insights about the market drivers, restrains and growth of the Biomaterials Market

Application Segmentation Insights

In 2023, the orthopedic segment accounted for the largest share of the biomaterials market. The use of metallic biomaterials in orthopedic applications, driven by their high load-bearing capacity, is a key factor contributing to the segment's growth. These biomaterials, such as titanium and its alloys, are preferred in orthopedic implants because of their strength, biocompatibility, and long-lasting performance. As the demand for joint replacements continues to grow due to the aging population and the increasing prevalence of musculoskeletal disorders, the orthopedic segment is expected to maintain its dominant position in the biomaterials market.

In addition to metallic biomaterials, continuous innovation in orthopedic implants is contributing to market expansion. For example, in November 2019, DiFusion Inc. received FDA approval for its Xiphos-ZF spinal interbody device, which features a novel biomaterial called Zfuze. This material combines poly-ether-ether-ketone (PEEK) and titanium to provide enhanced functionality in spinal surgeries. Zfuze has demonstrated significant reductions in cytokine markers, which are linked to inflammation and the formation of fibrous tissue around implants. This innovation underscores the ongoing efforts in the orthopedic field to develop more effective, biocompatible materials that can enhance patient outcomes.

Another significant trend is the growing demand for plastic surgery applications, which is expected to drive the fastest-growing segment of the biomaterials market. As the population ages and individuals increasingly seek cosmetic enhancements, the demand for cosmetic and reconstructive procedures is rising. Biomaterials play a crucial role in plastic and reconstructive surgeries, providing durable, customizable, and functional implants for aesthetic enhancements and post-trauma recovery.

Growth of the Plastic Surgery Segment

The plastic surgery segment of the biomaterials market is estimated to register the fastest CAGR over the forecast period, driven by a combination of factors. The demand for cosmetic procedures is growing, particularly in developed markets, where aesthetic procedures like facelifts, breast augmentations, and liposuction are becoming more common. Additionally, the need for reconstructive surgeries following accidents, trauma, or disease (such as breast reconstruction after mastectomy) is contributing to market growth.

The rise in aging populations, especially in developed countries, is another key factor driving the growth of the plastic surgery segment. As people live longer, there is an increased focus on maintaining a youthful appearance, which is fueling the demand for cosmetic surgeries. Biomaterials are critical in this field, as they are used in a wide range of procedures, including implants for facial reconstruction, breast implants, and other soft tissue implants. Advancements in biomaterials technology have also led to the development of more durable and customizable implants, making them increasingly appealing for both cosmetic and reconstructive purposes.

In addition, the growing obsession with youthful looks is particularly significant among younger populations, who are increasingly seeking cosmetic procedures to enhance or maintain their appearance. The ability to create personalized, high-quality biomaterial implants that meet specific aesthetic goals is fueling further growth in this segment.

Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.